Koite Health
Financials
Estimates*
EUR | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Revenues | - | - | <1m | <1m | <1m |
% growth | - | - | - | 119 % | 99 % |
EBITDA | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) |
% EBITDA margin | - | - | (93 %) | (136 %) | (128 %) |
Profit | (<1m) | (<1m) | (<1m) | (<1m) | (1.5m) |
% profit margin | - | - | (188 %) | (186 %) | (196 %) |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | N/A | €3.0m | Seed |
* | €4.0m | Early VC | |
Total Funding | CAD10.5m |
Recent News about Koite Health
EditKoite Health operates in the healthcare sector, focusing on innovative oral care solutions. The company targets both pediatric and adult dental hygiene markets, addressing common issues such as dental decay, gingivitis, and periodontitis. Koite Health's core product utilizes dual light antibacterial photodynamic therapy (PDT) to manage oral biofilm, a challenging bacterial matrix that traditional treatments often fail to address. This technology is designed to sustain oral bacterial diversity while significantly reducing harmful plaque bacteria, making it a reliable addition to regular brushing routines. The business model revolves around selling their advanced dental hygiene devices to consumers and healthcare providers. Revenue is generated through direct sales, partnerships with dental clinics, and potentially through licensing agreements for their patented technology. The market for Koite Health's products is vast, given the high prevalence of oral diseases globally. The company aims to expand its technology's application beyond oral care, leveraging its adaptability for broader healthcare uses.
Keywords: oral care, biofilm management, dual light therapy, dental hygiene, pediatric dentistry, photodynamic therapy, plaque reduction, healthcare innovation, bacterial control, dental technology.